Treatment of the blastic phase of chronic myeloid leukaemia. A question to solve.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D011687:Purines / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013440:Sulfides / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011687:Purines; D013440:Sulfides; D014631:Valerates; D003561:Cytarabine; D014750:Vincristine; D005998:Glycine; D006918:Hydroxyurea